2,5-Diphenyloxazole, approx. 99%, for scintillation, 500 g, plastic packaging.

L-4-Chlorophenylglycine, 98.0%, 10g

(R)-3-((tert-Butoxycarbonyl)amino)-4-(4-nitrophenyl)butanoic acid, 95.0%, 1g

4-Bromobenzo[b]thiophene, 95.0%, 1g

(4,4-Dimethylcyclohex-1-en-1-yl)boronic acid, 98%, 100mg

tert-Butyl ((5-bromothiophen-2-yl)methyl)carbamate, 95.0%, 1g

Tetrahydro-2H-pyran-2-one, 99.00%, 1g

5-Amino-1-(2,3-dichloro-phenyl)-1H-pyrazole-4-carbonitrile, 95.0%, 1g

9-Bromoacridine, 97%, 5g

1-Butyl-2-methyl-4-nitro-1H-imidazole, 97%, 5g

Methyl (Phenyl 5-Acetoxyacetamido-4,7,8-tri-O-acetyl-9-azido-3,5,9-trideoxy-2-thio-D-glycero-beta-D-galacto-2-nonulopyranosid)onate>93.0%(HPLC)100mg

N-(n-Heptyl)-n-octylamine, 97%, 1g

3-(2-Pyridyldithio)propanoic acid, 95.0%, 10g